Journal Of Modern Oncology

Periodical information

三才期刊采编系统
Acquisition System
（1993年创刊半月刊）

Sponsors: Chinese Anti-cancer Association
Shaanxi Anti-cancer Association of China
Shaanxi Cancer Institute

Editing & Publishing: Editorial Board of Journal of Modern Oncology
309 Yanta West Road Xi＇an Shaanxi Province 710061, P.R.China
Tel：0086-029-85578876
0086-029-85277356
0086-029-85276012
Fax:0086-029-85277356
http://www.xdzlyx.com/
E-mail：sxzlyx@263.net

Chief of Magazine Agency: Geng Qingyi(耿庆义)

Editor-in-Chief & Managing Director: Li Shuye(李树业)

Honorary editor in chief: Fan Daiming(樊代明)
Hao Xishan(郝希山)

Subscriptions

Domestic: Local Post Offices,China Post subscription code 52-297

Overseas: China International Book Trading Corporation
P.O.Box 399,Beijing 100044,China. Code No：M1985

Licence for Advertising: Shaanxi Industrial Commer-cial:6100004000094

Printing: Printing Branch of Xi＇an Haoxuan printing Co.Ltd

CSSN: ISSN 1672-4992
CN 61-1415/R

Price: RMB ￥10.00
US $6.00

Journal introduction

"Modern Oncology" (ISSN1672-4992, CN61-1415/R, semimonthly publication) is a nation-level domestic and foreign public released oncology periodical, proved by "Ministry of Chinese Science and Technique" and "News Publication Administration", also is one of the series periodicals of Chinese Anti-cancer Association. The journal is sponsored by Chinese Anti-cancer Association, Shaanxi Anti-cancer Association of China, Shaanxi Cancer Institute, Shaanxi Medical Academy of China and is managed by Shaanxi Scientific Technical Association. This journal is included by "Source Journals for Chinese Scientific and Technical Papers and Citations", "Chinese Scientific and Technical Core Periodical","A Guide to the Core Journals of China" , "Chemical Abstracts of USA", "Japan Science and Technology Agency(Chinese Bibliographic Database), JST China”， "Chinese Journal Net", "Chinese Academic Journal (CD-ROM Version) Full Text Database", "China Core Journals (Selection) Database", "Chinese Biomedical Literature Database", also is the full text internet journal of "Wanfang Data-Digital Periodical ", the source journal of "China Abstracts of Academic Periodicals"and "Chinese Medical Abstract•Oncology".更多...

Current Issue: 2024,Vol.32,NO.16

[2921-2929] Linc01419 regulates miR-34a-5p/E2F3 axis to promote proliferation and invasion of bladder cancer cells

[XIANG Wei,LYU Lei,ZHENG Fuxin,YUAN Jingdong,WU Wei]

2024 16 [Abstract]()

[2929-2936] The AKT/mTOR and MAPK pathway are involved in the induction of autophagy by Cucurbitacin B in non-small cell lung cancer cells

[CUI Qidi¹,LYU Guangyao²,ZHANG Jinjie²,SUN Shanshan¹,LU Mei^2,3,LYU Wenwen^2,3]

2024 16 [Abstract]()

[2937-2944] Effects of exosome-like nanovesicles from Selaginella doederleinii Hieron on proliferation,morphology,migration,invasion and apoptosis of hepatocellular carcinoma cells

[HU Ju¹,LIANG Zicheng¹,TAN Xiaoning²,ZHOU Fang²，ZENG Puhua^2,3]

2024 16 [Abstract]()

[2944-2951] Effects of Sinomenine regulating CXCR4-STAT3 axis on proliferation,migration and angiogenic mimicry of ovarian cancer A2780 cells

[YAN Zhenyu¹，GUO Meng²，YANG Ran³，SU Bo¹，ZHANG Haiyan⁴]

2024 16 [Abstract]()

[2951-2958] The mechanism of miR-4429 regulate endoplasmic reticulum stress pathway through PIK3R1 to affect the malignant phenotype of breast cancer

[ZHANG Yinghui¹,SHEN Liandi¹,LI Rui¹,SHANG Xiaohui¹,CAO Lingcong¹,YAN Jun²]

2024 16 [Abstract]()

[2959-2968] miR-34a inhibits the growth and metastasis of lung adenocarcinoma cells by blocking Wnt/β-catenin signaling pathway to downregulate PD-L1 expression

[LIU Xiaoqing,WANG Chunlou,ZHANG Xiaoling,XING Rongge,LIU Chunrong]

2024 16 [Abstract]()

[2969-2974] miR-93-5p regulates autophagy of HepG2 cells through the PI3K/AKT pathway

[ZHOU Man,CAO Ping,HOU Yilin,GAN Dingyun,LI Guangli,CHEN Wan,WU Jun]

2024 16 [Abstract]()

[2975-2981] UCHL1 promotes the proliferation and metastasis of lung cancer cells by regulating glycolytic metabolism in tumor microenvironment

[LI Aike,LIN Pingping,ZHAO Jiwei,GUO Yan,ZHANG Liguang,LI Fubo,DONG Yi,DU Xinsheng]

2024 16 [Abstract]()

[2981-2989] Catechin enhanced the killing effects of 5-FU on gastric cancer cells through promoting ferroptosis of gastric cancer cells

[XU Tao¹，JING Wenjun²，LIU Jing¹]

2024 16 [Abstract]()

[2990-2998] The effect and mechanism of CDK1 gene on proliferation and migration of hepatocellular carcinoma HepG2 and Huh7 cells

[YANG Ying,ZHANG Qimin,GUO Yufan,LI Huixin,ZHANG Shunbo,SUN Yu]

2024 16 [Abstract]()

[2999-3004] Value of fine needle puncture pathological examination in differentiating benign from malignant thyroid nodules and analysis of influencing factors on the quality of puncture specimens

[GUO Shanlan¹,ZHANG Lin¹,ZHOU Jie¹,LI Jing¹,WANG Wei¹,LI Changfen¹,SHEN Yang¹,TAO Shibing²]

2024 16 [Abstract]()

[3005-3010] The coexpression of Erbin,δ-catenin in non-small cell lung cancer and its relationship with prognosis

[LIU Shuaiying^1,2,3,ZHAN Yingting^2,3,LI Yanling^2,3,YU Jiale^2,3,WEI Xuelei^2,3,ZHANG Junyi^2,3]

2024 16 [Abstract]()

[3011-3018] Analysis of the efficacy of stereotactic radiotherapy combined with bevacizumab and PD-1 immunotherapy on brain metastases of non-small cell lung cancer

[ZHANG Yujie^1,2,3,SHI Hanfei^2,3,MAO Yong⁴,PAN Dejian^1,2,3]

2024 16 [Abstract]()

[3019-3023] Association between systemic immunoinflammatory index and pathological complete response of neoadjuvant chemotherapy for breast cancer

[YANG Yun，CHENG Fengfeng]

2024 16 [Abstract]()

[3024-3029] Expression of CDX2 in duodenal carcinoma tissues and its relationship with prognosis

[PAN Jun,CHEN Yitian,CHU Xiaoyuan]

2024 16 [Abstract]()

[3029-3037] Neoadjuvant chemotherapy increased postoperative complications of advanced gastric cancer

[JIN Zhuanmei^1,2,XU Li³,CHEN Min¹,WANG Rui¹,AN Yu¹,LI Shuangxi¹,YUAN Wenzhen^1,2]

2024 16 [Abstract]()

[3038-3051] Nomogram for predicting postoperative prognosis of gastric cancer patients based on SII and NLR

[SONG Buyun¹,SONG Chao¹,LIU Wenbo¹,LI Yong¹,WANG Bingyu¹,ZHANG Zaibo¹,CUI Jiaxiang¹,ZHAO Qun^1,2,ZHAO Xiaohan³,TAN Bibo^1,2]

2024 16 [Abstract]()

[3051-3059] Prognostic value of baseline geriatric nutritional risk index in elderly patients with multiple myeloma

[MIAO Yingjie,YUE Yanhua,ZHOU Yifang,CAO Yang,CHEN Huijuan,SHEN Yangling,GUO Yanting,GU Weiying]

2024 16 [Abstract]()

[3060-3065] Clinical observation of venetoclax combined with high-dose cytarabine in relapsed/refractory AML

[LEI Xiaoru，DAI Jinqian，LI Qiaoyan，SHI Rui，WEN Jing，WU Wen，REN Jingjing，LI Guang，SONG Yanping]

2024 16 [Abstract]()

[3066-3071] Clinical characteristics and prognostic analysis of pregnancy complicated with pheochromocytoma and paraganglioma

[LI Yun,GAO Hongbo,LI Longmin,CHEN Kailin,LIU Haichun,ZHANG Xiaoyong,SHAO Yujun]

2024 16 [Abstract]()

[3072-3077] Ovarian Sertoli-Leydig cell tumor:A clinicopathological analysis of 5 cases

[FANG Wanting,MING Jian,MENG Yingshuang,SHANG Jiawei]

2024 16 [Abstract]()

[3077-3084] Clinical analysis of large-volume renal epithelioid angiomyolipoma（maximum diameter＞4 cm）

[ZHANG Jun¹,YU Wenyi¹,JIN Lichen¹,HOU Jianquan^1,2]

2024 16 [Abstract]()

[3085-3092] Preoperative prediction of axillary lymph node metastasis in T1 breast cancer based on ABVS imaging nomogram

[ZHANG Yu¹，WANG Junli¹，FAN Lifang²，CHEN Guoxian²]

2024 16 [Abstract]()

[3093-3100] Study on the relationship between three dimensional mammary gland tomography signs and molecular classification and histological grade

[LI Dongxue¹,QIN Jinxia¹,ZHUANG Shan¹,XUN Mengya¹,DING Chao²]

2024 16 [Abstract]()

[3105-3110] Research progress on the effects of opioids on immunotherapy efficacy

[REN Jingyi^1，2，DENG Lin²，ZHU Liaoliao²，SONG Yang²]

2024 16 [Abstract]()

[3111-3117] Application progress of manganese-containing nanomaterials in tumor diagnosis and treatment

[DENG Lijuan，NIU Xiaofeng，REN Zheng，YANG Jun]

2024 16 [Abstract]()

[3117-3124] The mechanism of pyroptosis and its research progress in esophageal cancer

[HAN Yuting¹，ZHANG Xiaoqing²，WANG Fan¹，ZHAO Gelei¹，ZHANG Shan¹，LI Dongdong¹，LIU Peimin¹]

2024 16 [Abstract]()

[3125-3130] Research progress on roles of follicular helper T cells in malignant hematological diseases

[GONG Shan¹,ZHANG Ranran¹，QU Jianhua²]

2024 16 [Abstract]()

[3130-3137] Research progress of differentiation and metabolic reprogramming related to CD8+T cell depletion in tumor microenvironment

[LI Na¹，LI Xiurong²]

2024 16 [Abstract]()

[3138-3144] Mitochondrial dicarboxylate carrier SLC25A10:New targets for the prevention and treatment of tumors

[FANG Yu,ZHOU Yihan,ZHANG Qingchun,DING Weifeng,ZHANG Jianfeng]

2024 16 [Abstract]()

[3144-3149] Research progress of Notch signaling pathway regulating tumor-associated macrophage differentiation and influencing invasion of NSCLC cells

[DAI Can,KONG Yingjun,LIU Hang,ZHANG Na]

2024 16 [Abstract]()

[3150-3155] Research progress on the application of opioid free anesthesia in tumor surgery

[WANG Kai,ZHOU Wei，CHENG Chuanxi,CHEN Xiaobo]

2024 16 [Abstract]()

[3156-3160] Research progress on the tumor-promoting effects of cancer-associated fibroblasts and their targeted therapy

[ZENG Ruiqi¹,HE Weiyang²,ZENG Tiebing¹,CHEN Xiaobin¹]

2024 16 [Abstract]()

SITEMAP